Retrospective Observational non-interventional chart review study of patients with Pulmonary Arterial Hypertension (PAH) or Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Finland (FINPAH)

Study identification

• EU PAS number:
  EUPAS41732
• Study ID:
  41733
• Official title and acronym:
  Retrospective Observational non-interventional chart review study of patients with Pulmonary Arterial Hypertension (PAH) or Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Finland (FINPAH)
• DARWIN EU® study:
  No
• Study countries:
  Finland
• Study description:
  The study is an observational, retrospective, non-interventional patient chart review study, whose population is Finnish adult patients with a confirmed diagnosis of pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH), or with specific therapy for PAH or CTEPH initiated at any time between years 2008-2019. The primary aim is to investigat the real-life patient characteristics, treatment patterns and clinical outcomes of PAH and CTEPH patients in Finland during years 2008-2020. Secondary aim of the study is to examine direct and indirect costs associated with PAH and CTEPH.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Helsinki University Hospital (HYKS)

Tampere University Hospital

Finland

University of Turku

Tampere University Hospital Tampere, Finland, Turku University Central Hospital Turku, Finland, Oulu University Hospital Oulu, Finland, Kuopio University Hospital Kuopio, Finland

Study timelines

Date when funding contract was signed

Actual:10/02/2021

Study start date

Actual:21/04/2021

Date of final study report

Planned:30/09/2022

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Janssen-Cilag Oy

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable